https://www.selleckchem.com/pr....oducts/dl-buthionine
© 2018 Shenyang Pharmaceutical University. Published by Elsevier B.V.Anti-T-lymphocyte globulin (ATG) is frequently used in the induction regimen of renal transplantation, but its dose has not been standardized. In the present study, the efficacy of different ATG-Fresenius (ATG-F) doses was assessed in recipients of renal transplantation. A total of 131 adult recipients of renal transplantation who received ATG-F induction between August 2015 and July 2018 were included. The incidence of biopsy-confirmed acute rejectio
Aimer
Commentaire
Partagez
